-
Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page
NVS share price going to $70 or $60 or $100? :-)
- Thread starter anonymous
- Start date
-
- Tags
- None
Its a sad state...just lost $1,000 this week on NVS stock, even with a dividend payout I'll be hurting...hopefully the stock will rebound soon. Lots of factors as to the why...hard to stay loyal when almost 30% of the value is gone ($106-$76) in such a short time.
How NVS closes this week will give us another clue as to the short-term direction of the share price. Pay attention to the $72 level. If it holds, I expect maybe a nice rally back up to the $80-$85 level. You should sell some of your shares if you forgot to sell when they were trading north of $100. Looking at overall markets, they look ugly and we could be staring at another 20-30% drop across equities. This is what one could call the calm before the storm. Maybe.
How does this factor in to your forecast Mr. stock analyst?
- The end of US hegemonic influence in the Middle East
The policy of global expansion and domination of resources has hard limits on a finite planet.
It is time to share and spread the wealth around.
Reset ahead.
reset indeed. the spirit of scalia will hang over this country until moment of truth on election day.
NVS closed above $72, so there is a high probability, due to the short-term "oversold" nature of all equities, that we will see NVS trade north of $80 before the month of February concludes. Why should you care? Well, if you still hold an "out-sized" position in this company, you will want to be a seller and you do not want to be the last one out the exit door.
Agree. Damage is done but the stock is oversold...$82-83 will be the level I am out
NVS is losing because of their misrepresentation of Bexsero and and the thunderous lawsuits that will be coming from GSK. Wish you all well, but we told you here first.
The Sr Leadership and over all management SUCK. They are fricking delusional! Not every product is a blockbuster despite what they say and current performance in disappointing at best.
Couldn't have anything to do with the pricing of bonus shares for all the execs, could it? Kind of hard to make money on free stock priced in the 90's.
Watch the webcast and observer some old shareholder complain about why the stock price is so low.
http://edge.media-server.com/m/p/ye58e2rk/lan/en
HA HA HA !!! You own part of a company that helps extends and improves the lives of fellow humans and your one question to the Chairman is the share price performance?! Buy more if you think it's so cheap.
http://edge.media-server.com/m/p/ye58e2rk/lan/en
HA HA HA !!! You own part of a company that helps extends and improves the lives of fellow humans and your one question to the Chairman is the share price performance?! Buy more if you think it's so cheap.
If Trump wins the Presidential election, Big Pharma is going to suffer. He's made clear that he will negotiate pricing. Ironic that he employs the same strategy as the so-called socialist eurotrash countries.
I wouldn't be surprised if Novartis goes down to $30. But who cares, it's about the patients we care and cure right? Fuck the shareholders.
I wouldn't be surprised if Novartis goes down to $30. But who cares, it's about the patients we care and cure right? Fuck the shareholders.
"Caring and curing" is like so last year. "No pipeline, just pipedreams" I believe is the new one?